MarketInOut Stock Screener Log In | Sign Up

Marksans Pharma Ltd

BSE • Healthcare • Drug Manufacturers - General • Quote as of 10/27/2026 15:50
Marksans Pharma Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeBSE
Market Capitalization130,363 mln
Float214 mln
Earnings Date11/04/2026

EPS

7.76
Stretched

P / E

38.65
Overvalued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.27
Borderline

Relative Strength

44 / 100
Slightly lagging

Debt / Equity

0.11
Very low leverage

Business Description

Founded in 1992 and headquartered in Mumbai, India, Marksans Pharma Limited is a global pharmaceutical company that develops and manufactures a wide range of medicines across numerous health areas, including pain relief, heart health, diabetes, skin conditions, and respiratory care. The company produces tablets, capsules, oral liquids, creams, and ointments, which are sold across the United States, Europe, the United Kingdom, Australia, New Zealand, and other markets worldwide. Its products reach consumers through supermarkets, pharmacies, high street retailers, and wholesale distributors.

Key Fundamentals

EPS7.76
P/E38.65
ROE18.96
RPS60.24
ROIC19.27
ROA14.63
Interest Cover24.47
EBITDA, mln8,160
EV / EBITDA18.28
EV / EBIT20.84
Revenue, mln31,717
EV / Revenue4.70

Quote Details

Last 299.90
Change 4.15 (1.4%)
Open 300.25
Volume 60,828
Turnover 18,242,316
Average Volume 107,570

Financial Ratios

Pre-Tax Profit Margin22
Current Ratio5.17
Price / Book4.78
Price / Tangible Book5.05
Price / Cash Flow173
Price / Free Cash Flow41.61
Debt / Equity0.11
Price / Sales4.61
PEG Ratio1.92

Financial Strength

Altman Z-Score13.86
Piotroski F-Score 5 / 9
Beneish M-Score-2.27
Price to Intrinsic Value3.23
Price to Lynch Fair Value1.77
Price to Graham Number2.80
Shiller PE Ratio58.92

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.02% 69 / 100   
1 Month -11.04% 33 / 100   
2 Months 12.69% 84 / 100   
6 Months 58.19% 94 / 100   
1 Year 68% 94 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog